CDTX

Cidara Therapeutics INC

+$4.8B

Net Activity

Institutions Holding

256

Popularity Rank

#2289

Avg Weight

0.99%

Total Value

$8.0B

Ownership Trend

256 institutions currently hold CDTX, with 194 net buyers and 97 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2025)

Majority Increased

Based on recent trading activity

Net Selling Institutions

97

Net Buying Institutions

194

Key Holders

View all 256 holding institutions

Quarterly Activity

Recent Activity

+$28.7B

Total Buy Value

$2.1B

Total Sell Value

New buy130
Trim47
Add64
Sold out50

194

Net Buyers

97

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding CIDARA THERAPEUTICS INC (CDTX)?
Major stakeholders currently include Ra Capital Management, L.p. ($743.4M), Vanguard Group INC ($443.4M), BlackRock, Inc. ($371.2M). Based on the latest 13F filings, there are a total of 256 tracked investment funds and institutions maintaining positions in CDTX.
What is the overall institutional sentiment toward CDTX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $4.8B, driven by 194 managers accumulating shares while 97 reduced their exposure.
Which institutions have been selling or reducing their CDTX positions?
In the latest period, 47 funds trimmed their holdings, and 50 managers completely exited their positions. The aggregate reported sell value was $2.1B.
Are there any notable investors adding CDTX to their portfolios?
Yes, buying activity remains notable. 130 institutions opened new positions in {ticker}, and 64 existing holders added to their shares. The total reported buy value for the quarter amounted to $28.7B.

Related Stocks